Daemian Dussault

Title: Daemian Dussault: Innovator in Beta-Lactamase Inhibitor Compounds

Introduction

Daemian Dussault is a notable inventor based in Lowell, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitor compounds. With a total of 2 patents, his work is crucial in addressing bacterial infections, especially those caused by drug-resistant organisms.

Latest Patents

Dussault's latest patents focus on compounds that serve as beta-lactamase inhibitors. These compounds, along with their pharmaceutically acceptable salts, are designed to be used in combination with beta-lactam antibiotics or alone for the treatment of bacterial infections. This includes infections caused by multi-drug resistant organisms. The inventions include specific compounds according to a defined formula, which are detailed in the patent documentation.

Career Highlights

Daemian Dussault is currently associated with Entasis Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work is pivotal in the ongoing battle against antibiotic resistance, making him a key figure in modern medicine.

Collaborations

Dussault collaborates with talented professionals in his field, including Shanta Bist and Neil Bifulco. These partnerships enhance the research and development efforts at Entasis Therapeutics, Inc.

Conclusion

Daemian Dussault's contributions to the development of beta-lactamase inhibitor compounds are vital in the fight against bacterial infections. His innovative work and collaborations position him as a significant inventor in the pharmaceutical industry.